These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17609400

  • 1. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
    Kienitz T, Quinkler M, Strasburger CJ, Ventz M.
    Eur J Endocrinol; 2007 Jul; 157(1):39-46. PubMed ID: 17609400
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 3. A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas.
    van Varsseveld NC, Bisschop PH, Biermasz NR, Pereira AM, Fliers E, Drent ML.
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):395-402. PubMed ID: 23848527
    [Abstract] [Full Text] [Related]

  • 4. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Mar; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 5. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
    Nazato DM, Abucham J.
    J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
    [Abstract] [Full Text] [Related]

  • 9. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 10. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A, Fröss K, Kostecka-Matyja M, Sowa-Staszczak A, Szybiński Z, Huszno B, Ptak M.
    Przegl Lek; 2003 Aug; 60(11):768-71. PubMed ID: 15058054
    [Abstract] [Full Text] [Related]

  • 11. [Thyrotropin-producing hypophyseal adenomas].
    Calvo Romero JM, Morales Pérez F, Alvarez Barreiro JA, Díaz Pérez de Madrid J.
    Rev Clin Esp; 1999 May; 199(5):285-7. PubMed ID: 10396149
    [Abstract] [Full Text] [Related]

  • 12. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.
    Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of pituitary adenomas].
    Mezosi E, Nemes O.
    Orv Hetil; 2009 Sep 27; 150(39):1803-10. PubMed ID: 19758960
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin-secreting pituitary adenomas: report of seven cases.
    Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A.
    J Clin Endocrinol Metab; 1991 Feb 27; 72(2):477-83. PubMed ID: 1704011
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun 27; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM.
    J Formos Med Assoc; 2003 Mar 27; 102(3):164-71. PubMed ID: 12783133
    [Abstract] [Full Text] [Related]

  • 18. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.
    Sanno N, Teramoto A, Osamura RY.
    J Neurosurg; 2000 Aug 27; 93(2):194-200. PubMed ID: 10930003
    [Abstract] [Full Text] [Related]

  • 19. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
    Perticone F, Pigliaru F, Mariotti S, Deiana L, Furlani L, Mortini P, Losa M.
    Thyroid; 2015 Apr 27; 25(4):417-24. PubMed ID: 25647054
    [Abstract] [Full Text] [Related]

  • 20. [Thyroid-stimulating hormone pituitary adenomas: clinical characteristics, diagnosis and treatment].
    Xing B, Ren ZY, Su CB, Wang RZ, Yang Y, Ma WB, Li YN, Lian XL, Dai WX, Gu F.
    Zhonghua Wai Ke Za Zhi; 2011 Jun 01; 49(6):546-50. PubMed ID: 21914308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.